Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton)
Published April 16, 2025 · Recall initiated: March 21, 2025
Summary
FDA records drug Class II recall D-0354-2025, published April 16, 2025 and initiated March 21, 2025. Recalling firm: Somerset Therapeutics Private Limited; Status: Ongoing; Reported quantity: 506,080 vials; Lot: NDC 70069-101-25; A240304, A240305, A240320, A240322, A240334, A240335, A240340, exp. date 05/2026; A240342, A240347, A240385, A240391, exp. date 06/2026; NDC 70069-101-05; A240326, exp. date 05/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Media fill with bacterial contamination
What to do
Voluntary: Firm initiated · Letter
Get an email if METHOCARBAMOL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- METHOCARBAMOL
- Manufacturer
- Somerset Therapeutics Private Limited
- Distributor
- U.S. Nationwide
- UPC
- 0370069101018
- Lot
- NDC 70069-101-25; A240304, A240305, A240320, A240322, A240334, A240335, A240340, exp. date 05/2026; A240342, A240347, A240385, A240391, exp. date 06/2026; NDC 70069-101-05; A240326, exp. date 05/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDA0.9% Sodium chloride Irrigation USP, Isotonic Solution for Irrigation, 500 mL Plastic Irrigation ContainerApril 16, 2025
- FDAHaloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: SomersetApril 16, 2025
- FDAPropafenone Hydrochloride Extended-Release Capsules, USP 325mg,60-count bottles, Rx Only, Mfd for: NorthstarApril 16, 2025
- FDAHaloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset TherapeuticsApril 16, 2025
- FDAPropafenone Hydrochloride Extended-Release Capsules USP, 225mg 60-count bottles, Rx Only, Mfd by: GlenmarkApril 16, 2025
- FDAMethocarbamol Injection, USP 1000mg/10mL, (100mg/mL), 10 mL Single-Dose Vial packed 25 vials per carton, RxApril 17, 2024
Questions about this recall
Was Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton) recalled?
Yes. FDA published recall D-0354-2025 on April 16, 2025. Reported hazard: Lack of Assurance of Sterility: Media fill with bacterial contamination
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: METHOCARBAMOL. UPC: 0370069101018.